RBC Capital Maintains Outperform on Charles River, Raises Price Target to $322

9/25/2026
Impact: 75
Healthcare

RBC Capital analyst Ryan Halsted has maintained an Outperform rating on Charles River (NYSE: CRL) and raised the price target from $282 to $322. This adjustment reflects a positive outlook on the company's performance.

AI summary, not financial advice

Share: